GcNeu; NGNA; NeuNGl; Neu5Gc
3D model (JSmol)
|Molar mass||325.27 g/mol|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
N-Glycolylneuraminic acid (Neu5Gc) is a sialic acid molecule found in most non-human mammals. Humans cannot synthesize Neu5Gc because the human gene CMAH is irreversibly mutated, though it is found in apes. It is absent in human tissues because of inactivation of gene encoding CMP-N-acetylneuraminic acid hydroxylase. The gene CMAH encodes for CMP-N-acetylneuraminic acid hydroxylase, which is the enzyme responsible for CMP-Neu5Gc from CMP-N-acetylneuraminic (CMP-Neu5Ac) acid. This loss of CMAH is estimated to have occurred 2-3 million years ago, just before the emergence of the genus Homo.
Neu5Gc is closely related to the commonly known N-acetylneuraminic acid (Neu5Ac). Neu5Ac differs by a single oxygen atom that is added by the CMAH enzyme in the cytosol of a cell. In many mammals, both of these molecules are transferred into the Golgi so that they may be added to many glycoconjugates. However, in humans, Neu5Gc is not present.
With the loss of Neu5Gc gene and gain of excess Neu5Ac, it should have affected the interactions of pathogens and humans. Humans should have been less susceptible to Neu5Gc-binding pathogens and more susceptible to Neu5Ac-binding pathogens. It is suggested that human ancestors lacking Neu5Gc production survived a then-prevailing malaria epidemic. However, with the rise of Plasmodium falciparum, the parasite that causes malaria today, humans were once again endangered as this new strain of the malaria had a binding preference to the Neu5Ac-rich erythrocytes in humans. The latest research shows that humans who lack Neu5Ac on their red blood cells are less likely to get malaria from the parasites that cause it.
Neu5Gc is found in most mammals, with exceptions like humans, ferrets, the platypus, western dog breeds and New World monkeys. Trace amounts can be found in humans, even though the gene to encode for production of Neu5Gc was eliminated long ago. These trace amounts come from consumption of animals in human diet. Mainly, the sources are red meats such as lamb, pork, and beef. It can also be found in dairy products, but to a lesser extent. Some 1.1% of the identified Neu5Ac is actually Neu5Gc in commercial whey protein. Neu5Gc cannot be found in poultry and is found in only trace amounts in fish. This confirms that Neu5Gc is mainly found in foods of mammalian origin.Lanolin in shampoo also contains Neu5Gc.
In 2017, scientists succeeded in indirectly identifying the presence of Neu5GC from multiple ancient animal fossils dated to over a millions years ago, the oldest of which was dated to around 4 Mya.
Even though Neu5Gc is not known to be produced by any mechanism in the human body (due to lack of genes), our bodies do interact with trillions of microorganisms that are capable of complex biological reactions. Neu5Gc is reported to be found in concentration in human cancers, as well as in fecal samples, suggesting that humans ingest Neu5Gc as part of their diets. Uptake is thought to be by macropinocytosis, and the sialic acid can be transferred to the cytosol by a sialin transporter. It is possible that the immune system then recognizes the molecule as foreign, and that the binding of anti-Neu5Gc antibodies may then cause chronic inflammation. This assumption has yet to be concretely proven, however. Further studies have shown that humans have Neu5Gc-specific antibodies, often at high levels. Feeding Neu5Gc knockout mice Neu5Gc-rich diets along with anti-Neu5Gc antibodies (attempting to mimic a human system) causes systemic inflammation in the mice, and they are five times as likely to develop hepatocarcinomas.. However, a study released in September 2018 found no evidence that exposure to higher levels of anti-Neu5gc antibodies increased colon cancer risk. 
A baseline excretion of Neu5Gc exists, and it is incorporated into all body parts, some of which--mucins, hair, saliva, serum and blood, are commonly excreted. Neu5Gc is rapidly absorbed in the intestinal tract, some of which is converted to acylmannosamines by intestinal cells and bacteria, and reconverted back to Neu5Gc in the body. According to an absorption study, about 3-6% of the ingested dose of Neu5Gc was excreted within 4-6 hours, with the peak excretion rate at 2-3 h and a return to baseline levels within 24 h. In mucins, an increase was seen from day 1 to 4, with increased also found in hair after ingestion.This table and this table(S3) shows levels of Neu5Gc in common foods.
Sialic acids are negatively charged and hydrophilic, so they don't readily cross the hydrophobic regions of cellular membranes. It is because of this that the uptake of Neu5Gc must occur through an endocytic pathway. More specifically, exogenous Neu5Gc molecules enter cells through clathrin-independent endocytic pathways with help from pinocytosis. After the Neu5Gc has entered the cell via pinocytosis, the molecule is released by lysosomal sialidase. The molecule is then transferred into the cytosol by the lysosomal sialic acid transporter. From here, Neu5Gc are available for activation and addition to glycoconjugates. Because Neu5Gc appears to be enhanced in naturally occurring tumors and fetal tumors, it is suggested that this uptake mechanism is enhanced by growth factors.